PMS-LIDOCAINE VISCOUS 2% LIQUID

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

LIDOCAINE HYDROCHLORIDE

Disponible depuis:

PHARMASCIENCE INC

Code ATC:

N01BB02

DCI (Dénomination commune internationale):

LIDOCAINE

Dosage:

2%

forme pharmaceutique:

LIQUID

Composition:

LIDOCAINE HYDROCHLORIDE 2%

Mode d'administration:

DENTAL

Unités en paquet:

100,50 ML

Type d'ordonnance:

OTC

Domaine thérapeutique:

LOCAL ANESTHETICS

Descriptif du produit:

Active ingredient group (AIG) number: 0101280001; AHFS:

Statut de autorisation:

MARKETED

Date de l'autorisation:

1990-12-31

Résumé des caractéristiques du produit

PRESCRIBING INFORMATION
PMS-LIDOCAINE VISCOUS 2%
Lidocaine Hydrochloride Oral Topical Solution, USP
20 mg/mL
Oral Topical Anesthetic
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
www.pharmascience.com
Date of Revision:
April 6, 2016
Submission Control No: 193450
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 2 of 21 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................11
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................16
REFERENCES
..................................................................................................................17
PART III: CONSUMER
INFORMATION...............................................................................18
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 3 of 21 _
_ _
PMS-LIDOCAINE VISCOUS